Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

http://www.wikidata.org/entity/Q37996077

about

The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease Eryptosis as a marker of Parkinson's disease Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Catalytic enantioselective cyclization/cross-coupling with alkyl electrophiles.Investigational approaches to therapies for restless legs syndrome.Mavoglurant as a treatment for Parkinson's disease.Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.Cinnamamide Derivatives for Central and Peripheral Nervous System Disorders--A Review of Structure-Activity Relationships.Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.Use of monoamine oxidase inhibitors in chronic neurodegeneration.Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease.Rasagiline-induced severe recurrent hypoglycemia in a young woman without diabetes: a case report Rapid onset of efficacy of rasagiline in early Parkinson's disease.Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects.Safinamide: an add-on treatment for managing Parkinson's disease.

P2860

Q26745661-5021436E-5CA7-461F-93A9-80C829242EF1 Q34585744-DA23CFE9-7ED8-459A-B0CA-F01643E0958D Q36164724-06A4EA7E-CA15-46D2-B931-D9ED3EA29FEF Q37701007-FEA28B75-8045-4391-80D4-05237AB86600 Q38202686-25281762-E47E-43E7-8952-D0BFDD151B1C Q38222814-CE55593A-0D3E-49F3-A262-2AB9488385F0 Q38246682-6758EED2-E722-47F8-8537-4928A4B844F6 Q38260834-C08E1E79-483B-4823-BB40-762B5AD96D39 Q38530238-760BCEF2-CE70-45C0-B991-2A084526A7CE Q38817972-6C004C2A-DA77-4943-B893-5F67F2C2AAD5 Q39044780-0EB2205D-2BCC-4E40-A5F9-35B42F951951 Q39325939-2B5418CD-5F1A-4538-87FE-59487C168839 Q42112507-3C1EE97F-2730-4417-A37D-09DAF2BEA9C0 Q43781318-E9BB1D9C-D247-40F3-BB27-071C2D69E1B5 Q48192033-64E1CA84-EC72-47E4-AF4E-956769BC4C8B Q49843356-D9E3C1D7-64EB-4015-80B5-86C11AD36671 Q52804779-429B04B1-1D1D-432B-9303-B500C78DD0A6

P2860

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

http://www.wikidata.org/entity/Q37996077

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@en

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@nl

type

label

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@en

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@nl

prefLabel

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@en

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@nl

P1433

Q37996077-6C9A752D-53F2-42AD-8E12-6BDC099A1AFE

P1476

Q37996077-9FC3DCA3-3370-4871-BAF4-43E791B5AAFA

P2093

Q37996077-96172F8C-6F97-44D4-BCE9-394F22EB90A0

P2860

Q37996077-03211FF0-B023-4E85-A314-46E62BF6F781

Q37996077-05081B60-27E9-479A-808F-B5C3B2000D25

Q37996077-06512317-E99A-4BB9-8965-00EC7F8AFCCA

Q37996077-072B5C68-D52B-4888-B0AF-142F5BE807DB

Q37996077-0A6920D6-FC7F-4C23-91BD-753185C1942E

Q37996077-13252951-2401-4720-8E15-1D9826E65690

Q37996077-15A3CAA9-AD25-4CA5-96E5-B5359C064E59

Q37996077-17C5F5FE-EC35-46FB-B293-E672265C7DB1

Q37996077-26EC2CD9-8D08-41D6-9F03-F3F4D2397983

Q37996077-31C43B0D-4CF9-4088-9814-B4997C397F97

P2888

Q37996077-7D1E751A-B98D-43B7-B1BB-F8D12488B7DA

P304

Q37996077-84B2A9A7-E7CB-4BC2-B7D2-F7D0C2711C1B

P31

Q37996077-3CABCC90-41B5-4EE0-B322-9235C5C0D03E

P356

Q37996077-10C3D59F-5677-4866-84B5-4C7C3A24ADCF

P433

Q37996077-8DC2570C-5A38-4291-BD73-4576E28FEC98

P478

Q37996077-589E3197-C65F-4163-924F-CEB47C357A99

P50

Q37996077-643A7E35-FDB0-45F0-A75E-B30084449158

P577

Q37996077-B69398DC-588D-42F6-8F38-41D0F5C24BE7

P6179

Q37996077-86D9338E-D6C9-4780-982A-3605F871328D

P698

Q37996077-A75C9227-BA30-4DE1-BBBA-6391E0975CDF

P921

Q37996077-0AE0B461-27CA-4268-94F6-752FEC4EA641

P356

11207560-000000000-00000

P1433

P1476

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

@en

P2093

Sheridan M Hoy

http://www.w3.org/2001/XMLSchema#string

P2860

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

Rasagiline: a review of its use in the management of Parkinson's disease

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology.

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.

Meta-analysis of the relationship between Parkinson disease and melanoma.

Alternatives to levodopa in the initial treatment of early Parkinson's disease.

Advances in the pharmacologic management of early Parkinson disease.

P2888

11207560-000000000-00000

P304

643-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11207560-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Gillian M Keating

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033917490

http://www.w3.org/2001/XMLSchema#string

P698

22439669

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease